Tumors of the Lower Respiratory Tract

Remarkable advances have occurred since the 3rd Series Fascicle published in 1995 with paradigm shifts in every dimension of
our understanding of lung tumors including clinical, radiologic, histopathologic, cytopathologic, immunohistochemical,
molecular and therapeutic aspects.
The molecular revolution leading to effective targeted therapies and breakthroughs in immunotherapy for lung cancer have led to
novel approaches incorporating the concept of personalized medicine for patients who historically had little hope.
These advances have strengthened the place of pathologists to play a central role in the multidisciplinary team that is now
needed to properly diagnose and manage lung cancer patients.

Order the Tumors of the Lower Respiratory Tract AFIP atlas now to get a head start on these new discoveries and techniques for
diagnosing and treating these types of tumors.